Skip to content

Clinical trials

Completed Phase 3 Hyperlipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 3 Status: Completed Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20034
200412
200513
20068
20078
20083
20091
20102
20116
20122
201311
20145
20153
20165
20176
20192
20201
20215
20223
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed108

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer12
Amgen11
Takeda10
Esperion Therapeutics, Inc.5
Akeso3
AstraZeneca3
Hanmi Pharmaceutical Company Limited3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Merck Sharp & Dohme LLC3
Organon and Co3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias108
Hypercholesterolemia37
Hypertension19
Dyslipidemias16
Diabetes Mellitus9
Diabetes Mellitus, Type 29
Hyperlipoproteinemia Type II9
Atherosclerosis8
Hypertriglyceridemia7
Obesity7

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.